Improving HIV prevention for recently incarcerated men who inject drugs.
An intervention to improve HIV pre-exposure prophylaxis initiation, adherence and linkage to care for recently incarcerated men who inject drugs.
This study is looking to help recently released men who inject drugs start and stick with HIV prevention medication called PrEP by talking to them about their experiences and testing a new program called 'PrEPare-for-Release' to see how well it works.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rhode Island Hospital NIH-funded |
| Lab location | 1 site (Providence, United States) |
| Project ID | NIH-11076683 on NIH RePORTER |
What this research studies
This research focuses on enhancing the initiation and adherence to HIV pre-exposure prophylaxis (PrEP) among recently incarcerated men who inject drugs. It involves conducting interviews to understand the barriers and facilitators these individuals face regarding PrEP usage and developing a tailored intervention called 'PrEPare-for-Release.' The study will pilot this intervention with a small group and then conduct a randomized controlled trial to evaluate its effectiveness in improving access to and adherence to PrEP after release from incarceration.
Who could benefit from this research
Good fit: Ideal candidates for this research are recently incarcerated men who inject drugs and are at risk for HIV.
Not a fit: Patients who are not recently incarcerated or do not inject drugs may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly increase the uptake and adherence to HIV prevention methods among a high-risk population, potentially reducing new HIV infections.
How similar studies have performed: Other research has shown success in using tailored interventions to improve health outcomes in similar high-risk populations, indicating a promising approach.
Where this research is happening
Providence, United States
- Rhode Island Hospital — Providence, United States (Active)
Researchers
- Principal investigator: Murphy, Matthew — Rhode Island Hospital
- Study coordinator: Murphy, Matthew
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.